Efficacy and safety of combining re-irradiation with bevacizumab compared to bevacizumab alone in the management of recurrent high-grade gliomas: a meta-analysis and systematic review
Background: There is currently no established standard of care for recurrent glioblastoma (GBM). Re-irradiation (re-RT) and Bevacizumab (BEV) are both used in salvage treatment, but their combined efficacy remains uncertain. Objectives: To evaluate whether combining re-irradiation with BEV improves...
Saved in:
| Main Authors: | Ali Hammed, Almonzer Al-Qiami, Ali Hasan, Gregor Richter, Asmaa Zakria Alnajjar, Josef Rosenbauer, Karel Kostev, Omar Ismail, Veit Braun, Christian Tanislav |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/17562864251343574 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Re-irradiation combined with bevacizumab in the treatment of glioblastoma recurrence
by: S. V. Belokon, et al.
Published: (2024-03-01) -
Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases
by: Giammaria Fiorentini, et al.
Published: (2022-03-01) -
Efficacy and safety of bevacizumab in the treatment of adult gliomas: a systematic review and meta-analysis
by: Kai Wang, et al.
Published: (2021-12-01) -
Clinical outcomes of PRESERFLO Microshunt procedure with mitomycin C alone versus with mitomycin C and bevacizumab
by: Inas Gadelkarim, et al.
Published: (2025-04-01) -
Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective study
by: Bai Xuexue, et al.
Published: (2025-08-01)